% | $
Quotes you view appear here for quick access.

Avanir Pharmaceuticals, Inc. Message Board

  • greatdayforinvestments greatdayforinvestments Apr 28, 2013 10:42 AM Flag

    Fellow Longs (KEEP IN MIND) 2 potential other CNS indications (1) Autism & (2) Speech & Swallowing in ALS

    Building... a leading CNS platform
    Throughout fiscal 2012, we saw steady pipeline progress, including data presentations, regulatory submissions and clinical trial initiations.

    We have a number of potential indications that we believe our CNS platform can address. The results from the trials in the following areas are expected to be near- and mid-term catalysts for our business.

    Agitation in Alzheimer's disease
    Central neuropathic pain in multiple sclerosis
    Levodopa induced dyskinesia in Parkinson's disease
    Speech & Swallowing in ALS

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies